Evidence and research

• WEDINOS Nitazenes within the illicit benzodiazepine market

  This WEDINOS report highlights a concerning trend in the UK’s illicit drug market: the infiltration of highly potent synthetic opioids, specifically nitazenes, into substances sold as benzodiazepines. The report underscores […]

• WEDINOS MDMA: ecstasy and apathy

  This WEDINOS report highlights the increasing potency and variability of MDMA (ecstasy) tablets in the UK. The report emphasizes that the strength of MDMA tablets can vary widely, even within […]

• WEDINOS winter watchlist 2015

  This WEDINOS report highlights emerging concerns in the UK’s illicit drug market, particularly the prevalence of Synthetic Cannabinoid Receptor Agonists (SCRAs), synthetic opioids, and misrepresented MDMA samples.

• Pertussis (whooping cough) surveillance and epidemiology

  Epidemiology Pertussis incidence typically has a cyclical pattern with peaks in cases every three to four years. The peak prior to 2012 in England and Wales was in 2008, with […]

• Dried blood spot testing for hepatitis C, hepatitis B and HIV

  Summary This report outlines the background to, and action required for, the implementation of dried blood spot (DBS) testing of substance misuse service clients across Wales for evidence of exposure […]

• BSU report: Exploring factors influencing the application of behavioural science within public health practice across Wales

  A report into the exploration of factors influencing the application of behavioural science within public health practice across Wales. Behaviours play a key role in improving health and wellbeing.Identifying and […]

• Measles surveillance and epidemiology

  Epidemiology Measles has been notifiable in England and Wales since 1940, and notifications varied between 160,000 and 800,000 cases per year, the peaks occurring in two-year cycles. Before the introduction […]

• PPV uptake in Wales in 2023/24

  Background The pneumococcal polysaccharide vaccination (PPV) is currently offered to those aged 65 years and over and people aged two to 64 years in select clinical risk groups. PPV protects […]

• Inequalities in access to healthcare services: agile scoping report

  It includes information on the type of population groups and their demographic or socioeconomic characteristics identified in secondary research literature as associated with an inequality in access to a range […]

• Understanding social prescribing in Wales – a mixed methods study

  The aim of this work is to understand the landscape of social prescribing activity across Wales, and where possible, to quantify and describe its functions. To meet this aim we […]